Results 141 to 150 of about 4,267 (219)

Challenges in Performing Real-World Evidence Studies in Low-Middle Income Countries: the EdoBRA Study. [PDF]

Arq Bras Cardiol
Massaro AR.
europepmc   +1 more source

Adhesion al tratamiento anticoagulante.

, 2017
El tratamiento anticoagulante data de los años 40 y se ha basado, hasta hace poco tiempo, exclusivamente en dos fármacos Warfarina y Acenocumarol. Con los avances de la medicina, han surgido otros fármacos, aunque el más usado en nuestro país a día de hoy sigue siendo el Acenocumarol, a pesar de sus numerosas complicaciones (necesidad de ...
openaire   +1 more source

How to Improve Clinical Outcomes in Women with Atrial FibrillationReply. [PDF]

Arq Bras Cardiol
Kataoka N, Imamura T.
europepmc   +1 more source

[Usefulness of the H₂FPEF score in the diagnosis and prognosis of heart failure with preserved ejection fraction in primary care]. [PDF]

Aten Primaria
Cendrós V, Verdú-Rotellar JM, Parra J, Muñoz MÁ, Domingo M, Franch J.   +5 more
europepmc   +1 more source

INTERAÇÃO MEDICAMENTOSA COM ANTICOAGULANTES NO TRATAMENTO DE TROMBOSE VENOSA PROFUNDA (TVP)

INTERAÇÃO MEDICAMENTOSA COM ANTICOAGULANTES NOTRATAMENTO DE TROMBOSE VENOSA PROFUNDA ...
Harryson de Azevedo Nogueira
core  

[Theoretical Basis for Developing Cardiopulmonary Clinical Units in Patients with COPD and CVD]. [PDF]

Open Respir Arch
de Miguel-Díez J, Gómez Doblas JJ, Santos Pérez S, Recio Mayoral A, Manito Lorite N, Sobradillo Ecenarro P.   +5 more
europepmc   +1 more source

Registry of Percutaneous Closure of Patent Foramen Ovale in the Secondary Prevention of Stroke. [PDF]

Arq Bras Cardiol
Silveira ES, Machado GP, Teixeira JK, Fuchs F, Pinotti AF, Martins S, Wainstein MV.   +6 more
europepmc   +1 more source

Factors influencing the use of direct oral anticoagulants among patients with chronic chagas cardiomyopathy. [PDF]

Arch Peru Cardiol Cir Cardiovasc
Gómez-Ochoa SA, Rojas LZ, Alarcón Meléndez LJ, Quintero Santana MA, Becerra-Motta LP, Serrano-García AY, Echeverría LE.   +6 more
europepmc   +1 more source

Andexanet alfa for the management of severe bleeding: what should critical care physicians know about it? [PDF]

Crit Care Sci
Savioli F, Maiolino J, Rocha L.
europepmc   +1 more source